论文部分内容阅读
目的探讨舒利迭联合川芎嗪治疗中度哮喘的临床疗效。方法选择中度哮喘患者64例,给予舒利迭(50/250μg)1吸/次,2次/d;同时给予川芎嗪320mg+50g/L葡萄糖注射液250ml静脉滴注,1次/d。疗程为4周。监测治疗前后肺功能的变化,治疗后评定本组患者的治疗效果。结果本组患者治疗后,临床控制11例,显效25例,好转23例,无效5例,总有效率为92.3%;血治疗后肺功能比治疗前显著升高(P<0.05)。结论舒利迭联合川芎嗪治疗中度哮喘临床效果显著,值得临床借鉴。
Objective To investigate the clinical efficacy of seretide combined with ligustrazine in the treatment of moderate asthma. Methods Sixty-four patients with moderate asthma were given 1/2 times / day of seretide (50 / 250μg), and 250ml of ligustrazine 320mg + 50g / L glucose injection once per day. Treatment for 4 weeks. Monitoring changes in lung function before and after treatment, after treatment, the evaluation of the treatment effect of this group of patients. Results After treatment, 11 cases were clinically controlled, 25 cases were markedly effective, 23 cases were improved, 5 cases were ineffective and the total effective rate was 92.3%. The pulmonary function after treatment was significantly higher than that before treatment (P <0.05). Conclusion Seretide combined with ligustrazine in the treatment of moderate asthma clinical effect is significant, it is worth learning from.